Global Preventable Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Preventable Vaccines Industry Forecast” looks at past sales and reviews total world Preventable Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Preventable Vaccines sales for 2023 through 2029. With Preventable Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preventable Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Preventable Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preventable Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Preventable Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preventable Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preventable Vaccines.
The global Preventable Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Preventable Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Preventable Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Preventable Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Preventable Vaccines players cover GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical, Abbott, Roche and AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Preventable Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Preventable Vaccines market?
What factors are driving Preventable Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Preventable Vaccines market opportunities vary by end market size?
How does Preventable Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Preventable Vaccines Industry Forecast” looks at past sales and reviews total world Preventable Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Preventable Vaccines sales for 2023 through 2029. With Preventable Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preventable Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Preventable Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preventable Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Preventable Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preventable Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preventable Vaccines.
The global Preventable Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Preventable Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Preventable Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Preventable Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Preventable Vaccines players cover GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical, Abbott, Roche and AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Preventable Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Adult Preventable Vaccines
- Pediatric Preventable Vaccines
- Bacterial Diseases
- Virus Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Sanofi
- Takeda Pharmaceutical
- Abbott
- Roche
- AstraZeneca
- Mitsubishi Tanabe Pharma
- Lupin
- Serum Institute of India
- LG Life Sciences
- S K Chemicals
- Shenzhen Kangtai Biological Products
- Sinovac Biotech
- Janssen Pharmaceuticals
- Crucell
- Bavarian Nordic
- Baxter
- Bharat Biotech
- Dynavax
- Bausch Health
- Protein Sciences
- Panacea Biotec
What is the 10-year outlook for the global Preventable Vaccines market?
What factors are driving Preventable Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Preventable Vaccines market opportunities vary by end market size?
How does Preventable Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Preventable Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Preventable Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Preventable Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Preventable Vaccines Segment by Type
2.2.1 Adult Preventable Vaccines
2.2.2 Pediatric Preventable Vaccines
2.3 Preventable Vaccines Sales by Type
2.3.1 Global Preventable Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Preventable Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Preventable Vaccines Sale Price by Type (2018-2023)
2.4 Preventable Vaccines Segment by Application
2.4.1 Bacterial Diseases
2.4.2 Virus Diseases
2.5 Preventable Vaccines Sales by Application
2.5.1 Global Preventable Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Preventable Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Preventable Vaccines Sale Price by Application (2018-2023)
3 GLOBAL PREVENTABLE VACCINES BY COMPANY
3.1 Global Preventable Vaccines Breakdown Data by Company
3.1.1 Global Preventable Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Preventable Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Preventable Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Preventable Vaccines Revenue by Company (2018-2023)
3.2.2 Global Preventable Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Preventable Vaccines Sale Price by Company
3.4 Key Manufacturers Preventable Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preventable Vaccines Product Location Distribution
3.4.2 Players Preventable Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PREVENTABLE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Preventable Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Preventable Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Preventable Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Preventable Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Preventable Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Preventable Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Preventable Vaccines Sales Growth
4.4 APAC Preventable Vaccines Sales Growth
4.5 Europe Preventable Vaccines Sales Growth
4.6 Middle East & Africa Preventable Vaccines Sales Growth
5 AMERICAS
5.1 Americas Preventable Vaccines Sales by Country
5.1.1 Americas Preventable Vaccines Sales by Country (2018-2023)
5.1.2 Americas Preventable Vaccines Revenue by Country (2018-2023)
5.2 Americas Preventable Vaccines Sales by Type
5.3 Americas Preventable Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preventable Vaccines Sales by Region
6.1.1 APAC Preventable Vaccines Sales by Region (2018-2023)
6.1.2 APAC Preventable Vaccines Revenue by Region (2018-2023)
6.2 APAC Preventable Vaccines Sales by Type
6.3 APAC Preventable Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Preventable Vaccines by Country
7.1.1 Europe Preventable Vaccines Sales by Country (2018-2023)
7.1.2 Europe Preventable Vaccines Revenue by Country (2018-2023)
7.2 Europe Preventable Vaccines Sales by Type
7.3 Europe Preventable Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Preventable Vaccines by Country
8.1.1 Middle East & Africa Preventable Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Preventable Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Preventable Vaccines Sales by Type
8.3 Middle East & Africa Preventable Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preventable Vaccines
10.3 Manufacturing Process Analysis of Preventable Vaccines
10.4 Industry Chain Structure of Preventable Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Preventable Vaccines Distributors
11.3 Preventable Vaccines Customer
12 WORLD FORECAST REVIEW FOR PREVENTABLE VACCINES BY GEOGRAPHIC REGION
12.1 Global Preventable Vaccines Market Size Forecast by Region
12.1.1 Global Preventable Vaccines Forecast by Region (2024-2029)
12.1.2 Global Preventable Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Preventable Vaccines Forecast by Type
12.7 Global Preventable Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Preventable Vaccines Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Preventable Vaccines Product Portfolios and Specifications
13.2.3 Merck Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Preventable Vaccines Product Portfolios and Specifications
13.3.3 Novartis Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Preventable Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Preventable Vaccines Product Portfolios and Specifications
13.5.3 Sanofi Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Takeda Pharmaceutical
13.6.1 Takeda Pharmaceutical Company Information
13.6.2 Takeda Pharmaceutical Preventable Vaccines Product Portfolios and Specifications
13.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Takeda Pharmaceutical Main Business Overview
13.6.5 Takeda Pharmaceutical Latest Developments
13.7 Abbott
13.7.1 Abbott Company Information
13.7.2 Abbott Preventable Vaccines Product Portfolios and Specifications
13.7.3 Abbott Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbott Main Business Overview
13.7.5 Abbott Latest Developments
13.8 Roche
13.8.1 Roche Company Information
13.8.2 Roche Preventable Vaccines Product Portfolios and Specifications
13.8.3 Roche Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Roche Main Business Overview
13.8.5 Roche Latest Developments
13.9 AstraZeneca
13.9.1 AstraZeneca Company Information
13.9.2 AstraZeneca Preventable Vaccines Product Portfolios and Specifications
13.9.3 AstraZeneca Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 AstraZeneca Main Business Overview
13.9.5 AstraZeneca Latest Developments
13.10 Mitsubishi Tanabe Pharma
13.10.1 Mitsubishi Tanabe Pharma Company Information
13.10.2 Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolios and Specifications
13.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mitsubishi Tanabe Pharma Main Business Overview
13.10.5 Mitsubishi Tanabe Pharma Latest Developments
13.11 Lupin
13.11.1 Lupin Company Information
13.11.2 Lupin Preventable Vaccines Product Portfolios and Specifications
13.11.3 Lupin Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Lupin Main Business Overview
13.11.5 Lupin Latest Developments
13.12 Serum Institute of India
13.12.1 Serum Institute of India Company Information
13.12.2 Serum Institute of India Preventable Vaccines Product Portfolios and Specifications
13.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Serum Institute of India Main Business Overview
13.12.5 Serum Institute of India Latest Developments
13.13 LG Life Sciences
13.13.1 LG Life Sciences Company Information
13.13.2 LG Life Sciences Preventable Vaccines Product Portfolios and Specifications
13.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 LG Life Sciences Main Business Overview
13.13.5 LG Life Sciences Latest Developments
13.14 S K Chemicals
13.14.1 S K Chemicals Company Information
13.14.2 S K Chemicals Preventable Vaccines Product Portfolios and Specifications
13.14.3 S K Chemicals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 S K Chemicals Main Business Overview
13.14.5 S K Chemicals Latest Developments
13.15 Shenzhen Kangtai Biological Products
13.15.1 Shenzhen Kangtai Biological Products Company Information
13.15.2 Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolios and Specifications
13.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Shenzhen Kangtai Biological Products Main Business Overview
13.15.5 Shenzhen Kangtai Biological Products Latest Developments
13.16 Sinovac Biotech
13.16.1 Sinovac Biotech Company Information
13.16.2 Sinovac Biotech Preventable Vaccines Product Portfolios and Specifications
13.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Sinovac Biotech Main Business Overview
13.16.5 Sinovac Biotech Latest Developments
13.17 Janssen Pharmaceuticals
13.17.1 Janssen Pharmaceuticals Company Information
13.17.2 Janssen Pharmaceuticals Preventable Vaccines Product Portfolios and Specifications
13.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Janssen Pharmaceuticals Main Business Overview
13.17.5 Janssen Pharmaceuticals Latest Developments
13.18 Crucell
13.18.1 Crucell Company Information
13.18.2 Crucell Preventable Vaccines Product Portfolios and Specifications
13.18.3 Crucell Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Crucell Main Business Overview
13.18.5 Crucell Latest Developments
13.19 Bavarian Nordic
13.19.1 Bavarian Nordic Company Information
13.19.2 Bavarian Nordic Preventable Vaccines Product Portfolios and Specifications
13.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Bavarian Nordic Main Business Overview
13.19.5 Bavarian Nordic Latest Developments
13.20 Baxter
13.20.1 Baxter Company Information
13.20.2 Baxter Preventable Vaccines Product Portfolios and Specifications
13.20.3 Baxter Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Baxter Main Business Overview
13.20.5 Baxter Latest Developments
13.21 Bharat Biotech
13.21.1 Bharat Biotech Company Information
13.21.2 Bharat Biotech Preventable Vaccines Product Portfolios and Specifications
13.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Bharat Biotech Main Business Overview
13.21.5 Bharat Biotech Latest Developments
13.22 Dynavax
13.22.1 Dynavax Company Information
13.22.2 Dynavax Preventable Vaccines Product Portfolios and Specifications
13.22.3 Dynavax Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Dynavax Main Business Overview
13.22.5 Dynavax Latest Developments
13.23 Bausch Health
13.23.1 Bausch Health Company Information
13.23.2 Bausch Health Preventable Vaccines Product Portfolios and Specifications
13.23.3 Bausch Health Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Bausch Health Main Business Overview
13.23.5 Bausch Health Latest Developments
13.24 Protein Sciences
13.24.1 Protein Sciences Company Information
13.24.2 Protein Sciences Preventable Vaccines Product Portfolios and Specifications
13.24.3 Protein Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Protein Sciences Main Business Overview
13.24.5 Protein Sciences Latest Developments
13.25 Panacea Biotec
13.25.1 Panacea Biotec Company Information
13.25.2 Panacea Biotec Preventable Vaccines Product Portfolios and Specifications
13.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 Panacea Biotec Main Business Overview
13.25.5 Panacea Biotec Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Preventable Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Preventable Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Preventable Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Preventable Vaccines Segment by Type
2.2.1 Adult Preventable Vaccines
2.2.2 Pediatric Preventable Vaccines
2.3 Preventable Vaccines Sales by Type
2.3.1 Global Preventable Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Preventable Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Preventable Vaccines Sale Price by Type (2018-2023)
2.4 Preventable Vaccines Segment by Application
2.4.1 Bacterial Diseases
2.4.2 Virus Diseases
2.5 Preventable Vaccines Sales by Application
2.5.1 Global Preventable Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Preventable Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Preventable Vaccines Sale Price by Application (2018-2023)
3 GLOBAL PREVENTABLE VACCINES BY COMPANY
3.1 Global Preventable Vaccines Breakdown Data by Company
3.1.1 Global Preventable Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Preventable Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Preventable Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Preventable Vaccines Revenue by Company (2018-2023)
3.2.2 Global Preventable Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Preventable Vaccines Sale Price by Company
3.4 Key Manufacturers Preventable Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preventable Vaccines Product Location Distribution
3.4.2 Players Preventable Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PREVENTABLE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Preventable Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Preventable Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Preventable Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Preventable Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Preventable Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Preventable Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Preventable Vaccines Sales Growth
4.4 APAC Preventable Vaccines Sales Growth
4.5 Europe Preventable Vaccines Sales Growth
4.6 Middle East & Africa Preventable Vaccines Sales Growth
5 AMERICAS
5.1 Americas Preventable Vaccines Sales by Country
5.1.1 Americas Preventable Vaccines Sales by Country (2018-2023)
5.1.2 Americas Preventable Vaccines Revenue by Country (2018-2023)
5.2 Americas Preventable Vaccines Sales by Type
5.3 Americas Preventable Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preventable Vaccines Sales by Region
6.1.1 APAC Preventable Vaccines Sales by Region (2018-2023)
6.1.2 APAC Preventable Vaccines Revenue by Region (2018-2023)
6.2 APAC Preventable Vaccines Sales by Type
6.3 APAC Preventable Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Preventable Vaccines by Country
7.1.1 Europe Preventable Vaccines Sales by Country (2018-2023)
7.1.2 Europe Preventable Vaccines Revenue by Country (2018-2023)
7.2 Europe Preventable Vaccines Sales by Type
7.3 Europe Preventable Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Preventable Vaccines by Country
8.1.1 Middle East & Africa Preventable Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Preventable Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Preventable Vaccines Sales by Type
8.3 Middle East & Africa Preventable Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preventable Vaccines
10.3 Manufacturing Process Analysis of Preventable Vaccines
10.4 Industry Chain Structure of Preventable Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Preventable Vaccines Distributors
11.3 Preventable Vaccines Customer
12 WORLD FORECAST REVIEW FOR PREVENTABLE VACCINES BY GEOGRAPHIC REGION
12.1 Global Preventable Vaccines Market Size Forecast by Region
12.1.1 Global Preventable Vaccines Forecast by Region (2024-2029)
12.1.2 Global Preventable Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Preventable Vaccines Forecast by Type
12.7 Global Preventable Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Preventable Vaccines Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Preventable Vaccines Product Portfolios and Specifications
13.2.3 Merck Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Preventable Vaccines Product Portfolios and Specifications
13.3.3 Novartis Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Preventable Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Preventable Vaccines Product Portfolios and Specifications
13.5.3 Sanofi Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Takeda Pharmaceutical
13.6.1 Takeda Pharmaceutical Company Information
13.6.2 Takeda Pharmaceutical Preventable Vaccines Product Portfolios and Specifications
13.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Takeda Pharmaceutical Main Business Overview
13.6.5 Takeda Pharmaceutical Latest Developments
13.7 Abbott
13.7.1 Abbott Company Information
13.7.2 Abbott Preventable Vaccines Product Portfolios and Specifications
13.7.3 Abbott Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbott Main Business Overview
13.7.5 Abbott Latest Developments
13.8 Roche
13.8.1 Roche Company Information
13.8.2 Roche Preventable Vaccines Product Portfolios and Specifications
13.8.3 Roche Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Roche Main Business Overview
13.8.5 Roche Latest Developments
13.9 AstraZeneca
13.9.1 AstraZeneca Company Information
13.9.2 AstraZeneca Preventable Vaccines Product Portfolios and Specifications
13.9.3 AstraZeneca Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 AstraZeneca Main Business Overview
13.9.5 AstraZeneca Latest Developments
13.10 Mitsubishi Tanabe Pharma
13.10.1 Mitsubishi Tanabe Pharma Company Information
13.10.2 Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolios and Specifications
13.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mitsubishi Tanabe Pharma Main Business Overview
13.10.5 Mitsubishi Tanabe Pharma Latest Developments
13.11 Lupin
13.11.1 Lupin Company Information
13.11.2 Lupin Preventable Vaccines Product Portfolios and Specifications
13.11.3 Lupin Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Lupin Main Business Overview
13.11.5 Lupin Latest Developments
13.12 Serum Institute of India
13.12.1 Serum Institute of India Company Information
13.12.2 Serum Institute of India Preventable Vaccines Product Portfolios and Specifications
13.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Serum Institute of India Main Business Overview
13.12.5 Serum Institute of India Latest Developments
13.13 LG Life Sciences
13.13.1 LG Life Sciences Company Information
13.13.2 LG Life Sciences Preventable Vaccines Product Portfolios and Specifications
13.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 LG Life Sciences Main Business Overview
13.13.5 LG Life Sciences Latest Developments
13.14 S K Chemicals
13.14.1 S K Chemicals Company Information
13.14.2 S K Chemicals Preventable Vaccines Product Portfolios and Specifications
13.14.3 S K Chemicals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 S K Chemicals Main Business Overview
13.14.5 S K Chemicals Latest Developments
13.15 Shenzhen Kangtai Biological Products
13.15.1 Shenzhen Kangtai Biological Products Company Information
13.15.2 Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolios and Specifications
13.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Shenzhen Kangtai Biological Products Main Business Overview
13.15.5 Shenzhen Kangtai Biological Products Latest Developments
13.16 Sinovac Biotech
13.16.1 Sinovac Biotech Company Information
13.16.2 Sinovac Biotech Preventable Vaccines Product Portfolios and Specifications
13.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Sinovac Biotech Main Business Overview
13.16.5 Sinovac Biotech Latest Developments
13.17 Janssen Pharmaceuticals
13.17.1 Janssen Pharmaceuticals Company Information
13.17.2 Janssen Pharmaceuticals Preventable Vaccines Product Portfolios and Specifications
13.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Janssen Pharmaceuticals Main Business Overview
13.17.5 Janssen Pharmaceuticals Latest Developments
13.18 Crucell
13.18.1 Crucell Company Information
13.18.2 Crucell Preventable Vaccines Product Portfolios and Specifications
13.18.3 Crucell Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Crucell Main Business Overview
13.18.5 Crucell Latest Developments
13.19 Bavarian Nordic
13.19.1 Bavarian Nordic Company Information
13.19.2 Bavarian Nordic Preventable Vaccines Product Portfolios and Specifications
13.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Bavarian Nordic Main Business Overview
13.19.5 Bavarian Nordic Latest Developments
13.20 Baxter
13.20.1 Baxter Company Information
13.20.2 Baxter Preventable Vaccines Product Portfolios and Specifications
13.20.3 Baxter Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Baxter Main Business Overview
13.20.5 Baxter Latest Developments
13.21 Bharat Biotech
13.21.1 Bharat Biotech Company Information
13.21.2 Bharat Biotech Preventable Vaccines Product Portfolios and Specifications
13.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Bharat Biotech Main Business Overview
13.21.5 Bharat Biotech Latest Developments
13.22 Dynavax
13.22.1 Dynavax Company Information
13.22.2 Dynavax Preventable Vaccines Product Portfolios and Specifications
13.22.3 Dynavax Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Dynavax Main Business Overview
13.22.5 Dynavax Latest Developments
13.23 Bausch Health
13.23.1 Bausch Health Company Information
13.23.2 Bausch Health Preventable Vaccines Product Portfolios and Specifications
13.23.3 Bausch Health Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Bausch Health Main Business Overview
13.23.5 Bausch Health Latest Developments
13.24 Protein Sciences
13.24.1 Protein Sciences Company Information
13.24.2 Protein Sciences Preventable Vaccines Product Portfolios and Specifications
13.24.3 Protein Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Protein Sciences Main Business Overview
13.24.5 Protein Sciences Latest Developments
13.25 Panacea Biotec
13.25.1 Panacea Biotec Company Information
13.25.2 Panacea Biotec Preventable Vaccines Product Portfolios and Specifications
13.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 Panacea Biotec Main Business Overview
13.25.5 Panacea Biotec Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Preventable Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Preventable Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Adult Preventable Vaccines
Table 4. Major Players of Pediatric Preventable Vaccines
Table 5. Global Preventable Vaccines Sales by Type (2018-2023) & (K Units)
Table 6. Global Preventable Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Preventable Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Preventable Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Preventable Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Preventable Vaccines Sales by Application (2018-2023) & (K Units)
Table 11. Global Preventable Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Preventable Vaccines Revenue by Application (2018-2023)
Table 13. Global Preventable Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Preventable Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Preventable Vaccines Sales by Company (2018-2023) & (K Units)
Table 16. Global Preventable Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Preventable Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Preventable Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Preventable Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Preventable Vaccines Producing Area Distribution and Sales Area
Table 21. Players Preventable Vaccines Products Offered
Table 22. Preventable Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Preventable Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Preventable Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Preventable Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Preventable Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Preventable Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Preventable Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Preventable Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Preventable Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Preventable Vaccines Sales by Country (2018-2023) & (K Units)
Table 34. Americas Preventable Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Preventable Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Preventable Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Preventable Vaccines Sales by Type (2018-2023) & (K Units)
Table 38. Americas Preventable Vaccines Sales by Application (2018-2023) & (K Units)
Table 39. APAC Preventable Vaccines Sales by Region (2018-2023) & (K Units)
Table 40. APAC Preventable Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Preventable Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Preventable Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Preventable Vaccines Sales by Type (2018-2023) & (K Units)
Table 44. APAC Preventable Vaccines Sales by Application (2018-2023) & (K Units)
Table 45. Europe Preventable Vaccines Sales by Country (2018-2023) & (K Units)
Table 46. Europe Preventable Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Preventable Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Preventable Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Preventable Vaccines Sales by Type (2018-2023) & (K Units)
Table 50. Europe Preventable Vaccines Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Preventable Vaccines Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Preventable Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Preventable Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Preventable Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Preventable Vaccines Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Preventable Vaccines Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Preventable Vaccines
Table 58. Key Market Challenges & Risks of Preventable Vaccines
Table 59. Key Industry Trends of Preventable Vaccines
Table 60. Preventable Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Preventable Vaccines Distributors List
Table 63. Preventable Vaccines Customer List
Table 64. Global Preventable Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Preventable Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Preventable Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Preventable Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Preventable Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Preventable Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Preventable Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Preventable Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Preventable Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Preventable Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Preventable Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Preventable Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Preventable Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Preventable Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GlaxoSmithKline Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GlaxoSmithKline Preventable Vaccines Product Portfolios and Specifications
Table 80. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. GlaxoSmithKline Main Business
Table 82. GlaxoSmithKline Latest Developments
Table 83. Merck Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Preventable Vaccines Product Portfolios and Specifications
Table 85. Merck Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Novartis Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Preventable Vaccines Product Portfolios and Specifications
Table 90. Novartis Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Pfizer Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Preventable Vaccines Product Portfolios and Specifications
Table 95. Pfizer Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Sanofi Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Preventable Vaccines Product Portfolios and Specifications
Table 100. Sanofi Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Takeda Pharmaceutical Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Takeda Pharmaceutical Preventable Vaccines Product Portfolios and Specifications
Table 105. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Takeda Pharmaceutical Main Business
Table 107. Takeda Pharmaceutical Latest Developments
Table 108. Abbott Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbott Preventable Vaccines Product Portfolios and Specifications
Table 110. Abbott Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Abbott Main Business
Table 112. Abbott Latest Developments
Table 113. Roche Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Roche Preventable Vaccines Product Portfolios and Specifications
Table 115. Roche Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Roche Main Business
Table 117. Roche Latest Developments
Table 118. AstraZeneca Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. AstraZeneca Preventable Vaccines Product Portfolios and Specifications
Table 120. AstraZeneca Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. AstraZeneca Main Business
Table 122. AstraZeneca Latest Developments
Table 123. Mitsubishi Tanabe Pharma Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolios and Specifications
Table 125. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Mitsubishi Tanabe Pharma Main Business
Table 127. Mitsubishi Tanabe Pharma Latest Developments
Table 128. Lupin Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. Lupin Preventable Vaccines Product Portfolios and Specifications
Table 130. Lupin Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Lupin Main Business
Table 132. Lupin Latest Developments
Table 133. Serum Institute of India Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Serum Institute of India Preventable Vaccines Product Portfolios and Specifications
Table 135. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Serum Institute of India Main Business
Table 137. Serum Institute of India Latest Developments
Table 138. LG Life Sciences Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. LG Life Sciences Preventable Vaccines Product Portfolios and Specifications
Table 140. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. LG Life Sciences Main Business
Table 142. LG Life Sciences Latest Developments
Table 143. S K Chemicals Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. S K Chemicals Preventable Vaccines Product Portfolios and Specifications
Table 145. S K Chemicals Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. S K Chemicals Main Business
Table 147. S K Chemicals Latest Developments
Table 148. Shenzhen Kangtai Biological Products Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolios and Specifications
Table 150. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 151. Shenzhen Kangtai Biological Products Main Business
Table 152. Shenzhen Kangtai Biological Products Latest Developments
Table 153. Sinovac Biotech Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Sinovac Biotech Preventable Vaccines Product Portfolios and Specifications
Table 155. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 156. Sinovac Biotech Main Business
Table 157. Sinovac Biotech Latest Developments
Table 158. Janssen Pharmaceuticals Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Janssen Pharmaceuticals Preventable Vaccines Product Portfolios and Specifications
Table 160. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 161. Janssen Pharmaceuticals Main Business
Table 162. Janssen Pharmaceuticals Latest Developments
Table 163. Crucell Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Crucell Preventable Vaccines Product Portfolios and Specifications
Table 165. Crucell Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 166. Crucell Main Business
Table 167. Crucell Latest Developments
Table 168. Bavarian Nordic Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Bavarian Nordic Preventable Vaccines Product Portfolios and Specifications
Table 170. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 171. Bavarian Nordic Main Business
Table 172. Bavarian Nordic Latest Developments
Table 173. Baxter Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Baxter Preventable Vaccines Product Portfolios and Specifications
Table 175. Baxter Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 176. Baxter Main Business
Table 177. Baxter Latest Developments
Table 178. Bharat Biotech Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 179. Bharat Biotech Preventable Vaccines Product Portfolios and Specifications
Table 180. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 181. Bharat Biotech Main Business
Table 182. Bharat Biotech Latest Developments
Table 183. Dynavax Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 184. Dynavax Preventable Vaccines Product Portfolios and Specifications
Table 185. Dynavax Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 186. Dynavax Main Business
Table 187. Dynavax Latest Developments
Table 188. Bausch Health Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 189. Bausch Health Preventable Vaccines Product Portfolios and Specifications
Table 190. Bausch Health Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 191. Bausch Health Main Business
Table 192. Bausch Health Latest Developments
Table 193. Protein Sciences Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 194. Protein Sciences Preventable Vaccines Product Portfolios and Specifications
Table 195. Protein Sciences Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 196. Protein Sciences Main Business
Table 197. Protein Sciences Latest Developments
Table 198. Panacea Biotec Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 199. Panacea Biotec Preventable Vaccines Product Portfolios and Specifications
Table 200. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 201. Panacea Biotec Main Business
Table 202. Panacea Biotec Latest Developments
Table 1. Preventable Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Preventable Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Adult Preventable Vaccines
Table 4. Major Players of Pediatric Preventable Vaccines
Table 5. Global Preventable Vaccines Sales by Type (2018-2023) & (K Units)
Table 6. Global Preventable Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Preventable Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Preventable Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Preventable Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Preventable Vaccines Sales by Application (2018-2023) & (K Units)
Table 11. Global Preventable Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Preventable Vaccines Revenue by Application (2018-2023)
Table 13. Global Preventable Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Preventable Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Preventable Vaccines Sales by Company (2018-2023) & (K Units)
Table 16. Global Preventable Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Preventable Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Preventable Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Preventable Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Preventable Vaccines Producing Area Distribution and Sales Area
Table 21. Players Preventable Vaccines Products Offered
Table 22. Preventable Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Preventable Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Preventable Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Preventable Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Preventable Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Preventable Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Preventable Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Preventable Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Preventable Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Preventable Vaccines Sales by Country (2018-2023) & (K Units)
Table 34. Americas Preventable Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Preventable Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Preventable Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Preventable Vaccines Sales by Type (2018-2023) & (K Units)
Table 38. Americas Preventable Vaccines Sales by Application (2018-2023) & (K Units)
Table 39. APAC Preventable Vaccines Sales by Region (2018-2023) & (K Units)
Table 40. APAC Preventable Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Preventable Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Preventable Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Preventable Vaccines Sales by Type (2018-2023) & (K Units)
Table 44. APAC Preventable Vaccines Sales by Application (2018-2023) & (K Units)
Table 45. Europe Preventable Vaccines Sales by Country (2018-2023) & (K Units)
Table 46. Europe Preventable Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Preventable Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Preventable Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Preventable Vaccines Sales by Type (2018-2023) & (K Units)
Table 50. Europe Preventable Vaccines Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Preventable Vaccines Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Preventable Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Preventable Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Preventable Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Preventable Vaccines Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Preventable Vaccines Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Preventable Vaccines
Table 58. Key Market Challenges & Risks of Preventable Vaccines
Table 59. Key Industry Trends of Preventable Vaccines
Table 60. Preventable Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Preventable Vaccines Distributors List
Table 63. Preventable Vaccines Customer List
Table 64. Global Preventable Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Preventable Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Preventable Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Preventable Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Preventable Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Preventable Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Preventable Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Preventable Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Preventable Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Preventable Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Preventable Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Preventable Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Preventable Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Preventable Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GlaxoSmithKline Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GlaxoSmithKline Preventable Vaccines Product Portfolios and Specifications
Table 80. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. GlaxoSmithKline Main Business
Table 82. GlaxoSmithKline Latest Developments
Table 83. Merck Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Preventable Vaccines Product Portfolios and Specifications
Table 85. Merck Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Novartis Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Preventable Vaccines Product Portfolios and Specifications
Table 90. Novartis Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Pfizer Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Preventable Vaccines Product Portfolios and Specifications
Table 95. Pfizer Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Sanofi Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Preventable Vaccines Product Portfolios and Specifications
Table 100. Sanofi Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Takeda Pharmaceutical Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Takeda Pharmaceutical Preventable Vaccines Product Portfolios and Specifications
Table 105. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Takeda Pharmaceutical Main Business
Table 107. Takeda Pharmaceutical Latest Developments
Table 108. Abbott Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbott Preventable Vaccines Product Portfolios and Specifications
Table 110. Abbott Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Abbott Main Business
Table 112. Abbott Latest Developments
Table 113. Roche Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Roche Preventable Vaccines Product Portfolios and Specifications
Table 115. Roche Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Roche Main Business
Table 117. Roche Latest Developments
Table 118. AstraZeneca Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. AstraZeneca Preventable Vaccines Product Portfolios and Specifications
Table 120. AstraZeneca Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. AstraZeneca Main Business
Table 122. AstraZeneca Latest Developments
Table 123. Mitsubishi Tanabe Pharma Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolios and Specifications
Table 125. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Mitsubishi Tanabe Pharma Main Business
Table 127. Mitsubishi Tanabe Pharma Latest Developments
Table 128. Lupin Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. Lupin Preventable Vaccines Product Portfolios and Specifications
Table 130. Lupin Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Lupin Main Business
Table 132. Lupin Latest Developments
Table 133. Serum Institute of India Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Serum Institute of India Preventable Vaccines Product Portfolios and Specifications
Table 135. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Serum Institute of India Main Business
Table 137. Serum Institute of India Latest Developments
Table 138. LG Life Sciences Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. LG Life Sciences Preventable Vaccines Product Portfolios and Specifications
Table 140. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. LG Life Sciences Main Business
Table 142. LG Life Sciences Latest Developments
Table 143. S K Chemicals Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. S K Chemicals Preventable Vaccines Product Portfolios and Specifications
Table 145. S K Chemicals Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. S K Chemicals Main Business
Table 147. S K Chemicals Latest Developments
Table 148. Shenzhen Kangtai Biological Products Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolios and Specifications
Table 150. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 151. Shenzhen Kangtai Biological Products Main Business
Table 152. Shenzhen Kangtai Biological Products Latest Developments
Table 153. Sinovac Biotech Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Sinovac Biotech Preventable Vaccines Product Portfolios and Specifications
Table 155. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 156. Sinovac Biotech Main Business
Table 157. Sinovac Biotech Latest Developments
Table 158. Janssen Pharmaceuticals Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Janssen Pharmaceuticals Preventable Vaccines Product Portfolios and Specifications
Table 160. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 161. Janssen Pharmaceuticals Main Business
Table 162. Janssen Pharmaceuticals Latest Developments
Table 163. Crucell Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Crucell Preventable Vaccines Product Portfolios and Specifications
Table 165. Crucell Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 166. Crucell Main Business
Table 167. Crucell Latest Developments
Table 168. Bavarian Nordic Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Bavarian Nordic Preventable Vaccines Product Portfolios and Specifications
Table 170. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 171. Bavarian Nordic Main Business
Table 172. Bavarian Nordic Latest Developments
Table 173. Baxter Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Baxter Preventable Vaccines Product Portfolios and Specifications
Table 175. Baxter Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 176. Baxter Main Business
Table 177. Baxter Latest Developments
Table 178. Bharat Biotech Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 179. Bharat Biotech Preventable Vaccines Product Portfolios and Specifications
Table 180. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 181. Bharat Biotech Main Business
Table 182. Bharat Biotech Latest Developments
Table 183. Dynavax Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 184. Dynavax Preventable Vaccines Product Portfolios and Specifications
Table 185. Dynavax Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 186. Dynavax Main Business
Table 187. Dynavax Latest Developments
Table 188. Bausch Health Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 189. Bausch Health Preventable Vaccines Product Portfolios and Specifications
Table 190. Bausch Health Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 191. Bausch Health Main Business
Table 192. Bausch Health Latest Developments
Table 193. Protein Sciences Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 194. Protein Sciences Preventable Vaccines Product Portfolios and Specifications
Table 195. Protein Sciences Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 196. Protein Sciences Main Business
Table 197. Protein Sciences Latest Developments
Table 198. Panacea Biotec Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 199. Panacea Biotec Preventable Vaccines Product Portfolios and Specifications
Table 200. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 201. Panacea Biotec Main Business
Table 202. Panacea Biotec Latest Developments
LIST OF FIGURES
Figure 1. Picture of Preventable Vaccines
Figure 2. Preventable Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preventable Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Preventable Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Preventable Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Adult Preventable Vaccines
Figure 10. Product Picture of Pediatric Preventable Vaccines
Figure 11. Global Preventable Vaccines Sales Market Share by Type in 2022
Figure 12. Global Preventable Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Preventable Vaccines Consumed in Bacterial Diseases
Figure 14. Global Preventable Vaccines Market: Bacterial Diseases (2018-2023) & (K Units)
Figure 15. Preventable Vaccines Consumed in Virus Diseases
Figure 16. Global Preventable Vaccines Market: Virus Diseases (2018-2023) & (K Units)
Figure 17. Global Preventable Vaccines Sales Market Share by Application (2022)
Figure 18. Global Preventable Vaccines Revenue Market Share by Application in 2022
Figure 19. Preventable Vaccines Sales Market by Company in 2022 (K Units)
Figure 20. Global Preventable Vaccines Sales Market Share by Company in 2022
Figure 21. Preventable Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Preventable Vaccines Revenue Market Share by Company in 2022
Figure 23. Global Preventable Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Preventable Vaccines Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Preventable Vaccines Sales 2018-2023 (K Units)
Figure 26. Americas Preventable Vaccines Revenue 2018-2023 ($ Millions)
Figure 27. APAC Preventable Vaccines Sales 2018-2023 (K Units)
Figure 28. APAC Preventable Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. Europe Preventable Vaccines Sales 2018-2023 (K Units)
Figure 30. Europe Preventable Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Preventable Vaccines Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Preventable Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Americas Preventable Vaccines Sales Market Share by Country in 2022
Figure 34. Americas Preventable Vaccines Revenue Market Share by Country in 2022
Figure 35. Americas Preventable Vaccines Sales Market Share by Type (2018-2023)
Figure 36. Americas Preventable Vaccines Sales Market Share by Application (2018-2023)
Figure 37. United States Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Preventable Vaccines Sales Market Share by Region in 2022
Figure 42. APAC Preventable Vaccines Revenue Market Share by Regions in 2022
Figure 43. APAC Preventable Vaccines Sales Market Share by Type (2018-2023)
Figure 44. APAC Preventable Vaccines Sales Market Share by Application (2018-2023)
Figure 45. China Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Preventable Vaccines Sales Market Share by Country in 2022
Figure 53. Europe Preventable Vaccines Revenue Market Share by Country in 2022
Figure 54. Europe Preventable Vaccines Sales Market Share by Type (2018-2023)
Figure 55. Europe Preventable Vaccines Sales Market Share by Application (2018-2023)
Figure 56. Germany Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Preventable Vaccines Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Preventable Vaccines Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Preventable Vaccines Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Preventable Vaccines Sales Market Share by Application (2018-2023)
Figure 65. Egypt Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Preventable Vaccines in 2022
Figure 71. Manufacturing Process Analysis of Preventable Vaccines
Figure 72. Industry Chain Structure of Preventable Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Preventable Vaccines Sales Market Forecast by Region (2024-2029)
Figure 75. Global Preventable Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Preventable Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Preventable Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Preventable Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Preventable Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Preventable Vaccines
Figure 2. Preventable Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preventable Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Preventable Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Preventable Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Adult Preventable Vaccines
Figure 10. Product Picture of Pediatric Preventable Vaccines
Figure 11. Global Preventable Vaccines Sales Market Share by Type in 2022
Figure 12. Global Preventable Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Preventable Vaccines Consumed in Bacterial Diseases
Figure 14. Global Preventable Vaccines Market: Bacterial Diseases (2018-2023) & (K Units)
Figure 15. Preventable Vaccines Consumed in Virus Diseases
Figure 16. Global Preventable Vaccines Market: Virus Diseases (2018-2023) & (K Units)
Figure 17. Global Preventable Vaccines Sales Market Share by Application (2022)
Figure 18. Global Preventable Vaccines Revenue Market Share by Application in 2022
Figure 19. Preventable Vaccines Sales Market by Company in 2022 (K Units)
Figure 20. Global Preventable Vaccines Sales Market Share by Company in 2022
Figure 21. Preventable Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Preventable Vaccines Revenue Market Share by Company in 2022
Figure 23. Global Preventable Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Preventable Vaccines Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Preventable Vaccines Sales 2018-2023 (K Units)
Figure 26. Americas Preventable Vaccines Revenue 2018-2023 ($ Millions)
Figure 27. APAC Preventable Vaccines Sales 2018-2023 (K Units)
Figure 28. APAC Preventable Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. Europe Preventable Vaccines Sales 2018-2023 (K Units)
Figure 30. Europe Preventable Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Preventable Vaccines Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Preventable Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Americas Preventable Vaccines Sales Market Share by Country in 2022
Figure 34. Americas Preventable Vaccines Revenue Market Share by Country in 2022
Figure 35. Americas Preventable Vaccines Sales Market Share by Type (2018-2023)
Figure 36. Americas Preventable Vaccines Sales Market Share by Application (2018-2023)
Figure 37. United States Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Preventable Vaccines Sales Market Share by Region in 2022
Figure 42. APAC Preventable Vaccines Revenue Market Share by Regions in 2022
Figure 43. APAC Preventable Vaccines Sales Market Share by Type (2018-2023)
Figure 44. APAC Preventable Vaccines Sales Market Share by Application (2018-2023)
Figure 45. China Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Preventable Vaccines Sales Market Share by Country in 2022
Figure 53. Europe Preventable Vaccines Revenue Market Share by Country in 2022
Figure 54. Europe Preventable Vaccines Sales Market Share by Type (2018-2023)
Figure 55. Europe Preventable Vaccines Sales Market Share by Application (2018-2023)
Figure 56. Germany Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Preventable Vaccines Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Preventable Vaccines Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Preventable Vaccines Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Preventable Vaccines Sales Market Share by Application (2018-2023)
Figure 65. Egypt Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Preventable Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Preventable Vaccines in 2022
Figure 71. Manufacturing Process Analysis of Preventable Vaccines
Figure 72. Industry Chain Structure of Preventable Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Preventable Vaccines Sales Market Forecast by Region (2024-2029)
Figure 75. Global Preventable Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Preventable Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Preventable Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Preventable Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Preventable Vaccines Revenue Market Share Forecast by Application (2024-2029)
More Publications
Global Medical ECG Telemetry Equipment Market Growth 2025-2031
US$ 3,660.00
February 2025
104 pages
Global Trisenox Market Growth 2024-2030
US$ 3,660.00
March 2024
75 pages
Global Amino Acid Metabolism Disease Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
105 pages
